Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract

Wen Lun Wang, Wei Lun Chang, Yi Chun Yeh, Ching Tai Lee, Chi Yang Chang, Jaw Town Lin, Bor Shyang Sheu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) are elevated in patients with squamous cell carcinoma (SCC) over either the head and neck (HNSCC) or the esophagus (ESCC). Synchronous SCC with both HNSCC and ESCC predispose to worse survival. This study tested if serum MMP levels correlate with clinical features and predict survival for HNSCC, ESCC, and synchronous SCC. One hundred and thirty patients with SCCs in upper aero-digestive tract (70 ESCC, 20 HNSCC, and 40 synchronous SCC) and 74 healthy controls were assessed for serum MMP-3, -7, and -9 titers by enzyme-linked immunosorbent assay. The titers were validated to their correlations to clinical features and survival rates of the different SCC groups. Patients with SCCs had significantly higher serum MMP-3, -7, and -9 titers than the controls (P<0.001) but there was no difference among the three SCC groups. Based on the optimal MMP cut-off values by ROC curve, elevated MMP-3 and MMP-9, but not MMP-7, correlated with distant metastasis and poor survival (P<0.05). Concomitantly elevated MMP-3 (>14ng/mL) and MMP-9 (>329.3ng/mL) independently correlated with poor two-year survival (P=0.002, by log rank test). Cox regression confirmed that such concomitant elevation was superior to the tumor stage of either ESCC or HNSCC in predicting survival for synchronous SCC. Serum MMPs are elevated in SCC of the upper aero-digestive tract. Especially for synchronous SCC, concomitantly elevated MMP-3 and MMP-9 levels serve as better biomarkers to predict prognosis than TNM staging of ESCC or HNSCC.

Original languageEnglish
Pages (from-to)438-445
Number of pages8
JournalMolecular Carcinogenesis
Volume52
Issue number6
DOIs
Publication statusPublished - 2013 Jun 1

Fingerprint

Matrix Metalloproteinase 3
Matrix Metalloproteinase 9
Gastrointestinal Tract
Squamous Cell Carcinoma
Survival
Serum
Matrix Metalloproteinases
Matrix Metalloproteinase 7
Neoplasm Staging
Esophagus
Neck
Survival Rate
Biomarkers
Enzyme-Linked Immunosorbent Assay
Head

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cancer Research

Cite this

@article{a9656b8cc43a4b009ce491fee88aaf99,
title = "Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract",
abstract = "Matrix metalloproteinases (MMPs) are elevated in patients with squamous cell carcinoma (SCC) over either the head and neck (HNSCC) or the esophagus (ESCC). Synchronous SCC with both HNSCC and ESCC predispose to worse survival. This study tested if serum MMP levels correlate with clinical features and predict survival for HNSCC, ESCC, and synchronous SCC. One hundred and thirty patients with SCCs in upper aero-digestive tract (70 ESCC, 20 HNSCC, and 40 synchronous SCC) and 74 healthy controls were assessed for serum MMP-3, -7, and -9 titers by enzyme-linked immunosorbent assay. The titers were validated to their correlations to clinical features and survival rates of the different SCC groups. Patients with SCCs had significantly higher serum MMP-3, -7, and -9 titers than the controls (P<0.001) but there was no difference among the three SCC groups. Based on the optimal MMP cut-off values by ROC curve, elevated MMP-3 and MMP-9, but not MMP-7, correlated with distant metastasis and poor survival (P<0.05). Concomitantly elevated MMP-3 (>14ng/mL) and MMP-9 (>329.3ng/mL) independently correlated with poor two-year survival (P=0.002, by log rank test). Cox regression confirmed that such concomitant elevation was superior to the tumor stage of either ESCC or HNSCC in predicting survival for synchronous SCC. Serum MMPs are elevated in SCC of the upper aero-digestive tract. Especially for synchronous SCC, concomitantly elevated MMP-3 and MMP-9 levels serve as better biomarkers to predict prognosis than TNM staging of ESCC or HNSCC.",
author = "Wang, {Wen Lun} and Chang, {Wei Lun} and Yeh, {Yi Chun} and Lee, {Ching Tai} and Chang, {Chi Yang} and Lin, {Jaw Town} and Sheu, {Bor Shyang}",
year = "2013",
month = "6",
day = "1",
doi = "10.1002/mc.21874",
language = "English",
volume = "52",
pages = "438--445",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "6",

}

Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract. / Wang, Wen Lun; Chang, Wei Lun; Yeh, Yi Chun; Lee, Ching Tai; Chang, Chi Yang; Lin, Jaw Town; Sheu, Bor Shyang.

In: Molecular Carcinogenesis, Vol. 52, No. 6, 01.06.2013, p. 438-445.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract

AU - Wang, Wen Lun

AU - Chang, Wei Lun

AU - Yeh, Yi Chun

AU - Lee, Ching Tai

AU - Chang, Chi Yang

AU - Lin, Jaw Town

AU - Sheu, Bor Shyang

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Matrix metalloproteinases (MMPs) are elevated in patients with squamous cell carcinoma (SCC) over either the head and neck (HNSCC) or the esophagus (ESCC). Synchronous SCC with both HNSCC and ESCC predispose to worse survival. This study tested if serum MMP levels correlate with clinical features and predict survival for HNSCC, ESCC, and synchronous SCC. One hundred and thirty patients with SCCs in upper aero-digestive tract (70 ESCC, 20 HNSCC, and 40 synchronous SCC) and 74 healthy controls were assessed for serum MMP-3, -7, and -9 titers by enzyme-linked immunosorbent assay. The titers were validated to their correlations to clinical features and survival rates of the different SCC groups. Patients with SCCs had significantly higher serum MMP-3, -7, and -9 titers than the controls (P<0.001) but there was no difference among the three SCC groups. Based on the optimal MMP cut-off values by ROC curve, elevated MMP-3 and MMP-9, but not MMP-7, correlated with distant metastasis and poor survival (P<0.05). Concomitantly elevated MMP-3 (>14ng/mL) and MMP-9 (>329.3ng/mL) independently correlated with poor two-year survival (P=0.002, by log rank test). Cox regression confirmed that such concomitant elevation was superior to the tumor stage of either ESCC or HNSCC in predicting survival for synchronous SCC. Serum MMPs are elevated in SCC of the upper aero-digestive tract. Especially for synchronous SCC, concomitantly elevated MMP-3 and MMP-9 levels serve as better biomarkers to predict prognosis than TNM staging of ESCC or HNSCC.

AB - Matrix metalloproteinases (MMPs) are elevated in patients with squamous cell carcinoma (SCC) over either the head and neck (HNSCC) or the esophagus (ESCC). Synchronous SCC with both HNSCC and ESCC predispose to worse survival. This study tested if serum MMP levels correlate with clinical features and predict survival for HNSCC, ESCC, and synchronous SCC. One hundred and thirty patients with SCCs in upper aero-digestive tract (70 ESCC, 20 HNSCC, and 40 synchronous SCC) and 74 healthy controls were assessed for serum MMP-3, -7, and -9 titers by enzyme-linked immunosorbent assay. The titers were validated to their correlations to clinical features and survival rates of the different SCC groups. Patients with SCCs had significantly higher serum MMP-3, -7, and -9 titers than the controls (P<0.001) but there was no difference among the three SCC groups. Based on the optimal MMP cut-off values by ROC curve, elevated MMP-3 and MMP-9, but not MMP-7, correlated with distant metastasis and poor survival (P<0.05). Concomitantly elevated MMP-3 (>14ng/mL) and MMP-9 (>329.3ng/mL) independently correlated with poor two-year survival (P=0.002, by log rank test). Cox regression confirmed that such concomitant elevation was superior to the tumor stage of either ESCC or HNSCC in predicting survival for synchronous SCC. Serum MMPs are elevated in SCC of the upper aero-digestive tract. Especially for synchronous SCC, concomitantly elevated MMP-3 and MMP-9 levels serve as better biomarkers to predict prognosis than TNM staging of ESCC or HNSCC.

UR - http://www.scopus.com/inward/record.url?scp=84876454392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876454392&partnerID=8YFLogxK

U2 - 10.1002/mc.21874

DO - 10.1002/mc.21874

M3 - Article

C2 - 22241750

AN - SCOPUS:84876454392

VL - 52

SP - 438

EP - 445

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 6

ER -